SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-045191
Filing Date
2024-05-20
Accepted
2024-05-20 16:15:45
Documents
70
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0206431-10q_aditxtinc.htm   iXBRL 10-Q 1213720
2 CERTIFICATION ea020643101ex31-1_aditxtinc.htm EX-31.1 11135
3 CERTIFICATION ea020643101ex31-2_aditxtinc.htm EX-31.2 11380
4 CERTIFICATION ea020643101ex32-1_aditxtinc.htm EX-32.1 5734
  Complete submission text file 0001213900-24-045191.txt   7919160

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE adtx-20240331.xsd EX-101.SCH 77558
6 XBRL CALCULATION FILE adtx-20240331_cal.xml EX-101.CAL 36942
7 XBRL DEFINITION FILE adtx-20240331_def.xml EX-101.DEF 428644
8 XBRL LABEL FILE adtx-20240331_lab.xml EX-101.LAB 693429
9 XBRL PRESENTATION FILE adtx-20240331_pre.xml EX-101.PRE 424739
74 EXTRACTED XBRL INSTANCE DOCUMENT ea0206431-10q_aditxtinc_htm.xml XML 803151
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39336 | Film No.: 24964669
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)